PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
114 hedge funds and large institutions have $324M invested in Paratek Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 21 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $419M → $324M (-$95.5M)
44% less call options, than puts
Call options by funds: $934K | Put options by funds: $1.67M
Holders
114
Holding in Top 10
3
Calls
$934K
Puts
$1.67M
Top Buyers
| 1 | +$9.51M | |
| 2 | +$7.54M | |
| 3 | +$7.21M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.74M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$12M | |
| 3 | -$2.77M | |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
-$2.56M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$2.26M |